Can long term therapy with oral nucleos(t)ide analogs influence the prognosis of chronic hepatitis B-related complications?

被引:2
|
作者
Ooi, Marie [1 ,2 ]
Teoh, Narci C. [1 ,2 ]
机构
[1] Canberra Hosp, Gastroenterol & Hepatol Unit, Garran, ACT 2604, Australia
[2] Canberra Hosp, Australian Natl Univ Med Sch, Garran, ACT 2604, Australia
关键词
HEPATOCELLULAR-CARCINOMA; LAMIVUDINE; VACCINATION; MANAGEMENT; TRIAL;
D O I
10.1111/j.1440-1746.2012.07221.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1541 / 1543
页数:3
相关论文
共 50 条
  • [1] Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents
    Kim, Chang Ha
    Um, Soon Ho
    Seo, Yeon Seok
    Jung, Jin Yong
    Kim, Jin Dong
    Yim, Hyung Joon
    Keum, Bora
    Kim, Yong Sik
    Jeen, Yoon Tae
    Lee, Hong Sik
    Chun, Hoon Jai
    Kim, Chang Duck
    Ryu, Ho Sang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (10) : 1589 - 1595
  • [2] Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Petersen, Joerg
    Buti, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 683 - 694
  • [3] Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma
    Wong, G. L. -H.
    Tse, Y. -K.
    Chan, H. L. -Y.
    Yip, T. C. -F.
    Tsoi, K. K. -F.
    Wong, V. W. -S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (07) : 802 - 813
  • [4] Long-term effect of nucleos (t)ide analogs on hepatitis B surface antigen in chronic hepatitis B patients
    Morikawa, Kenichi
    Umemura, Machiko
    Ogawa, Koji
    Shigesawa, Taku
    Suzuki, Kazuharu
    Nakamura, Akihisa
    Ohara, Masatsugu
    Kawagishi, Naoki
    Shimazaki, Tomoe
    Kimura, Megumi
    Izumi, Takaaki
    Nakai, Masato
    Sho, Takuya
    Suda, Goki
    Natsuizaka, Mitsuteru
    Ono, Kota
    Murata, Kazumoto
    Sugiyama, Masaya
    Masashi, Mizokami
    Sakamoto, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E477 - E477
  • [5] Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure
    Hu, Ting
    Yao, Lipeng
    Hu, Airong
    Jiang, Suwen
    Ying, Hao
    Deng, Qinzhi
    Hu, Yaoren
    Zhou, Wenhong
    Xiong, Tao
    HEPATOLOGY RESEARCH, 2017, 47 (04) : 347 - 358
  • [6] Renal Abnormality in Chronic Hepatitis B Patients Treated with Oral Nucleos(t)ide Analogs
    Seansawat, Kitisak
    Tanwandee, Tawesak
    HEPATOLOGY, 2012, 56 : 380A - 381A
  • [7] Renal abnormality in chronic hepatitis B patients treated with oral nucleos(t)ide analogs
    Seansawat, Kitisak
    Tanwandee, Tawesak
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 242 - 243
  • [8] Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
    Ibragimov, E. K.
    Abdurakhmanov, D. T.
    Rozina, T. P.
    Nikulkina, E. N.
    Tanaschuk, E. L.
    Odintsov, A., V
    Panevkina, S., V
    Moiseev, S., V
    TERAPEVTICHESKII ARKHIV, 2019, 91 (02) : 40 - 47
  • [9] Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy
    Wang, Meng-Lan
    Chen, En-Qiang
    Tao, Chuan-Min
    Zhou, Tao-You
    Liao, Juan
    Zhang, Dong-Mei
    Wang, Juan
    Tang, Hong
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) : 1420 - 1426
  • [10] Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    Ridruejo, Ezequiel
    Silva, Marcelo O.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 357 - 360